Characteristics | N = 84 |
---|---|
Age (years) | |
Median/Range | 62 (27–83) |
Sex (male/female) | 53 (63%)/31 (37%) |
Preoperative chemotherapy (+/−) | 66 (79%)/18 (21%) |
Preoperative radiation therapy (+/−) | 3 (4%)/81 (96%) |
Tumor differentiation (well differentiated tubular adenocarcinoma/moderately differentiated tubular adenocarcinoma/mucinous adenocarcinoma) | 43/37/4 |
Pathological T stage (T0/Tis/T1/T2/T3/T4) | 6/1/8/21/37/11 |
Pathological N stage (N0/N1/N2/) | 51/18/15 |
LLN metastasis (+/−) | 15 (18%)/69 (82%) |
The median number of resected LLND Right side / Left side | 9 (6–12)/ 10 (7–13) |
Location of LLN metastasis (263R/263 L/273R/273 L/283R/283 L/293R/293 L) | 4/5/0/0/6/5/0/1 |
Median and variance of short axis diameter for lateral lymph nodes Positive [median, variance]/ negative [median, variance] | [10, 10.31/ 4.8, 3.8] |
Median and variance of SUVmax for lateral lymph nodes positive [median, variance]/ negative [median, variance] | [1.9, 17.7 / 0.91, 0.24] |
Pathological stage 0/I/II/III/IV | 6/22/20/22/14 |
Primary tumor SUVmax | 14.2 ± 6.89 |
LLN SUVmax | 1.4 ± 1.70 |